CAMP4 Therapeutics Stock (NASDAQ:CAMP)


ForecastChart

Previous Close

$5.46

52W Range

$3.50 - $12.30

50D Avg

$4.82

200D Avg

$6.63

Market Cap

$111.89M

Avg Vol (3M)

$74.32K

Beta

-7.00

Div Yield

-

CAMP Company Profile


CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

53

IPO Date

Oct 11, 2024

Website

CAMP Performance


Latest Earnings Call Transcripts


Q2 23Sep 22, 22 | 8:13 PM
Q1 23Jun 23, 22 | 11:56 PM
Q4 22Apr 28, 22 | 10:50 PM

Peer Comparison


TickerCompany
KNKnowles Corporation
COMMCommScope Holding Company, Inc.
HLITHarmonic Inc.
AVNWAviat Networks, Inc.
ADTNADTRAN Holdings, Inc.
CASACasa Systems, Inc.
NTGRNETGEAR, Inc.
ITRNIturan Location and Control Ltd.
KVHIKVH Industries, Inc.
DGIIDigi International Inc.
CMTLComtech Telecommunications Corp.
FEIMFrequency Electronics, Inc.